Firm Events
District Court vs. PTAB: Strategic Forum Selection in Life Sciences Patent Disputes
December 10, 2026 | 12:00 PM – 1:00 PM ET
Tom Rose, a partner in Troutman Pepper’s Corporate Practice Group, was quoted in the November 4, 2024 Law360 article, “US IPO Activity Hits Standstill as Election Takes Center Stage.”
“If Trump were to prevail, the sentiment generally is that a Trump administration would reduce some of the regulatory barriers and burdens in certain industries — for example in the life science sector and with cryptocurrencies — and it probably would jumpstart the IPO and capital markets environment generally for those industries and others starting early in 2025,” Troutman Pepper Hamilton Sanders LLP’s Thomas Rose told Law360.
Whereas if Harris wins, Rose added, market participants expect a “continuation of the same in terms of the regulatory environment” — at least for a period of time.
Insight Industries + Practices
This just in
Speaking Engagements
Performance on Trial: The Construction Manager’s Standard of Care Examined from All Angles
December 2, 2026 | 4:15 PM – 5:30 PM ET
The Hyatt Regency Huntington Beach
Huntington Beach, CA
Speaking Engagements
ACI’s 31st Annual Conference on Drug & Medical Device Litigation – 2026
December 2 – 3, 2026
New York Marriott Marquis
1535 Broadway, New York, NY 10036
Speaking Engagements
Fundamentals of Investment Adviser Regulation 2026
November 19, 2026 | 2:30 PM – 3:30 PM ET
PLI New York
1177 Avenue of the Americas, Entrance on 45th Street, New York, NY 10036